ArticleScientific reports2026
Precision pharmacology: deep learning infused ontological framework with E-GRU enhancement for tailored medicine prescriptions.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced Clinical Decision Support Systems significantly influence patient care, with medicine prescriptions being a vital area of research. Ontology, a growing discipline in the semantic web, enables hierarchical domain representation, thereby allowing finer data access to be achieved. Deep Learning (DL) supports pattern recognition in Electronic Health Records (EHR), which include patient demographics and diagnosis histories. Prescribing medications with minimal adverse effects is crucial, particularly for patients who require multiple drugs, as drug interactions can result in more complex conditions. This study introduces an integrated approach that combines Ontology with DL neural networks to improve prescription accuracy. This study proposes NexusOpti, a model featuring an Enhanced Gated Recurrent Unit (E-GRU) layer. To understand drug-disease interactions, hierarchical data were extracted from the International Classification of Diseases (ICD) and Anatomical Therapeutic Chemical (ATC) ontologies. These structured data were processed using a self-attention mechanism to enhance the recommendation precision. This integration not only addresses data security concerns but also improves the accuracy of the medicine recommendations. The model was evaluated using key metrics such as the hit ratio and normalised discounted cumulative gain (NDCG). The NexusOpti model, incorporating the Enhanced Gated Recurrent Unit (E-GRU) layer, outperforms the existing GRU model in terms of NDCG and Hit Ratio metrics. 13% of improvement in performance was oberved to the comparison between NexusOpti with the E-GRU and the GRAM baseline model. These findings highlight the effectiveness of the model in advancing personalised, safer, and data-driven medication prescriptions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.